Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate

Am J Hematol. 2009 May;84(5):302-5. doi: 10.1002/ajh.21383.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Benzamides
  • Biopsy, Needle
  • Bone Marrow / pathology
  • Chromosomes, Human, Pair 22 / genetics
  • Chromosomes, Human, Pair 9 / genetics
  • Female
  • Humans
  • Hyperplasia
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Middle Aged
  • Neutropenia / drug therapy
  • Piperazines / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / therapeutic use*

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases